DS-5141b

DRUG2 trials

Sponsors

Daiichi Sankyo Co., Ltd.

Conditions

Duchenne Muscular Dystrophy

Phase 1

Study of DS-5141b in Patients With Duchenne Muscular Dystrophy

CompletedNCT02667483

Daiichi Sankyo Co., Ltd.Duchenne Muscular Dystrophy

Start: 2015-10-31End: 2020-10-20Updated: 2024-03-07

Phase 2

Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy

Active, not recruitingNCT04433234

Daiichi Sankyo Co., Ltd.Duchenne Muscular Dystrophy

Start: 2020-06-30End: 2027-01-31Target: 8Updated: 2025-09-19